Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France [0.03%]
法国由超广谱β-内酰胺酶产生菌引起的医院相关感染抗生素治疗的变迁历程
Marion Lecuru,Côme Daniau,Serge Alfandari et al.
Marion Lecuru et al.
Background: Infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) remain a public health challenge. Aim: ...
Corynebacterium glucuronolyticum in men with and without urethritis syndrome: An underrecognized pathogen or a bona fide commensal? [0.03%]
解脲支原体以外的男性尿道炎致病菌：葡萄糖发酵棒状杆菌？
T Meštrović,M Neuberg,M Sviben et al.
T Meštrović et al.
Background: By analysing the largest collection of Corynebacterium glucuronolyticum (C. glucuronolyticum) isolates from a single centre thus far, we aimed to appraise a potential causal link between an infrequently isolat...
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis [0.03%]
耐碳青霉烯类抗生素ESBL产酶肠杆菌科细菌感染性心内膜炎的 ceftazidime-avibactam和cefepime-vaborycan治疗效果及机制研究-cefoxitin联合疗法用于ESBL产生型肠杆菌目细菌心内膜炎
P Danneels,C Rihet,C Vannier et al.
P Danneels et al.
Background: Endocarditis due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is a rare but challenging condition. Its treatment relies on carbapenems alone or in combination, and no alternative has...
Hiroshi Ito
Hiroshi Ito
Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France [0.03%]
法国康复病房中产超广谱β-内酰胺酶肠杆菌科细菌定植的流行率及危险因素
I Grall-Zahar,S Rucly,Typhaine Billard-Pomares et al.
I Grall-Zahar et al.
Objectives: Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are a major public health concern worldwide. Little is known about the prevalence of ESBL-PE colonization in rehabilitation wards in France...
Respiratory tract outbreak modeling with case definition criteria: A proposal for a standardized clinical approach in nursing homes [0.03%]
基于病例定义标准的呼吸道传染病爆发模拟：对护理机构临床标准化方法的建议
P Gaspard,K Ambert-Balay,A Mosnier et al.
P Gaspard et al.
Objectives: This study aimed to monitor respiratory tract outbreaks in nursing homes (NH) by applying standardized case definition criteria, pathogen identification and estimated mortality impact. ...
Observational Study
Infectious diseases now. 2022 Sep;52(6):365-370. DOI:10.1016/j.idnow.2022.07.002 2022
Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 season [0.03%]
2020—2021赛季法国职业足球运动员新冠肺炎发病及特点分析
David Luque-Paz,Emmanuel Orhant,Fabrice Michel et al.
David Luque-Paz et al.
Objectives: To describe the epidemiology of COVID-19 in French professional football players, and to compare the infection incidence with the general population across the first three waves. ...
Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster [0.03%]
有或没有SARS-CoV-2感染的BNT162b2疫苗加强针接种者中的抗SARS-CoV-2 IgG抗体水平
G L Salvagno,B M Henry,G Lippi
G L Salvagno
B C Bono,S Olei,Z Rossini et al.
B C Bono et al.
Should anti-malarial chemoprophylaxis be reimbursed in France? A cost-effectiveness analysis of different reimbursement strategies [0.03%]
法国应不应该为抗疟疾化学药物预防提供经济补偿？不同经济补偿策略的成本效益分析
C Fiorina,J-M Josselin,M Trépart-Normand et al.
C Fiorina et al.
Objectives: France is the Western country with the highest number of imported malaria cases. This study evaluates the cost and effectiveness of the potential reimbursement of drugs for malaria chemoprophylaxis (CP). It ta...